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similar infections
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Abstract
Background: Many people have multiple infections at the same time, but the combined contribution of those
infections to disease-related mortality is unknown. Registered causes of death offer a unique opportunity to study
associations between multiple infections.
Methods: We analysed over 900,000 death certificates that reported infectious causes of death. We tested whether
reports of multiple infections (i.e., co-infections) differed across individuals’ age or sex. We also tested whether each pair
of infections were reported together more or less often than expected by chance, and whether this co-reporting was
associated with the number of biological characteristics they had in common.
Results: In England and Wales, and the USA, 10 and 6 % respectively of infection-related deaths involved co-infection.
Co-infection was reported reported most often in young adults; 30 % of infection-related deaths among those aged
25–44 from the USA, and 20 % of infection-related deaths among those aged 30–39 from England and Wales, reported
multiple infections. The proportion of infection-related deaths involving co-infection declined with age more slowly in
males than females, to less than 10 % among those aged >65. Most associated pairs of infections co-occurred more often
than expected from their frequency of being reported alone (488/683 [71 %] in the USA, 129/233 [55 %] in England and
Wales), and tended to share biological characteristics (taxonomy, transmission mode, tropism or timescale).
Conclusions: Age, sex, and biologically similar infections are associated with death from co-infection, and may help
indicate patients at risk of severe co-infection.
Background
Infectious diseases cause 25 % of human mortality world-
wide; in 2008, respiratory infections caused 4.26 million
deaths, diarrhoea caused 2.16 million deaths, and HIV/
AIDS caused over 2 million deaths [1]. However, the role
of co-infection (more than one simultaneous infection
in an individual) in this mortality is unknown. Some
co-infections are known to cause death; for example
HIV-tuberculosis co-infection caused 350,000 deaths
worldwide in 2008 [2], and bacterial pneumonia in-
creases the risk of death from influenza [3]. While some
co-infections are not detrimental, most papers report a
negative effect of co-infection on human health [4].
Despite previous reports of negative health effects, we
know little about the characteristics of people who died
from co-infection.
A key question is whether deaths due to co-infection are
predictable, and what factors influence this. Demographic
characteristics (i.e., age, sex) of individuals could be im-
portant determinants of whether co-infection is reported
on a death certificate. Older people and males are typically
more susceptible to infectious disease than younger
people and females [5–7]. There is evidence of age and
sex biases for certain co-infections; most measles deaths
are from viral or bacterial co-infection in young females
[8], whereas sepsis deaths are higher in males than females
[9]. Whether deaths from many different co-infections
generally differ by age or sex is unclear.
Characteristics of the infecting organisms could also
underlie associations among reported infections. We
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hypothesise that biologically similar pairs of infections
co-occur more often than expected. For example, taxo-
nomically similar infections may coinfect due to similar
life cycles, targeted organs, or antigens [10, 11]. Shared
transmission routes may promote co-infection, e.g., blood-
borne viral infections among injecting drug users [12].
Similarly, chronic infections in the same body part may
exacerbate morbidity (e.g., hepatitis viruses A and C [13]).
An alternate hypothesis is that antagonistic interactions
are stronger between more similar infections, and thus
would be found together less often.
The characteristics of people who died with co-infections
can be studied using causes of death reported on death cer-
tificates. These data offer a general description of co-
infection-associated death in humans, providing broad con-
text for other co-infection research, and enable tests of spe-
cific, public-health relevant hypotheses about co-infection.
Here, we use death certificates to test for relationships be-
tween co-infection-related deaths and individual age and
sex, and explore how similarities in biological characteris-
tics (taxonomy, transmission, tropism, and timescale) re-
lated to associations between reported infections.
We gathered data on reported infectious causes of
death across a recent four-year time period in England
and Wales, and the USA. These data offer a novel op-
portunity to study how infections associate with one an-
other at death, and the contribution of characteristics of
both the individual and the infections. We address three
hypotheses: (i) the proportion of infection deaths attrib-
uted to multiple infections differs by age and sex, (ii) the
frequency of pairs of infections co-occurring on death
certificates differs from that expected from the occur-
rence of each infection alone, and (iii) the frequency of
co-occurrence of each pair of infections on death certifi-
cates increases with similarity in terms of taxonomic
group, transmission route, tropism, and timescale.
Methods
Death certificates in England and Wales report one under-
lying cause of death and up to 15 contributory factors, fol-
lowing the International Classification of Diseases (ICD
[14]). We used 139,459 death certificates from 2005 to
2008 in England and Wales that reported at least one infec-
tion and followed ICD-10. In England and Wales 2005–08
was the longest recent time period within which ICD codes
were interpreted consistently. In the USA, one main and up
to 20 extra causes of death are listed on death certifications
following ICD-10. There were 816,390 death certificates
from 2005 to 2008 in the USA that reported at least one in-
fection. By infection we mean a type of infectious disease
classified in ICD, not necessarily a particular pathogen.
In ICD-10, one infection code explicitly indicates co-
infection (‘B20’, which denotes other infections arising
from HIV infection). Other co-infections are indicated by
multiple infections reported on the death certificate. Here-
after, the term “single infection death” indicates death
certificates with only one infection reported, and “co-
infection death” indicates death certificates with more
than one infection reported.
Data for England and Wales were obtained from the
Office for National Statistics. Other data provided were
sex and age at death (eight age categories: 0–19, 20–29,
30–39, 70–79, 80+). Other information, (i.e., exact age,
date and place of death, higher resolution ICD codes)
were removed by the Office for National Statistics to
prevent identification of individuals.
Data for the USA were downloaded from http://
www.nber.org/data/multicause.html. For comparability
with England and Wales we ensured similar ICD coding,
and roughly decadal categories, while also keeping higher
resolution data available among children (<1, 1–4, 5–14,
15–24, 25–34, 75–84, 85+). We also used data on place of
death (e.g., patients in hospital, hospice, or nursing home)
to test whether the patterns were consistent among inpa-
tients with access to treatment before death.
Ethical approval
We use data from public agencies in the US and the UK
that relate to deceased humans. We were exempt from
requiring ethical approval to undertake our study be-
cause the individuals were not living when the data were
gathered (US federal regulations 45 CFR 46.102f Protec-
tion of Human Subjects 2009). We also worked with the
Office for National Statistics to ensure that data they
supplied and the results that we report herein did not
disclose personal or sensitive data relating to living per-
sons (Freedom of Information Act 2000 c. 36 II section
40(3)(a)).
Statistical analyses
(i) Age, sex, and co-infection death
Associations between age, sex, and co-infection
death were modelled using generalised additive
models (GAM) with two predictor variables: sex
(two level factor; male and female) and age (eight
level factor for England and Wales, eleven level
factor for the USA), and the interaction between
age and sex. This analysis is similar to a logistic
(i.e., binomial) regression where the response
variable is the number of “successes” (co-infection
death) and “failures” (single infection death) with
binomial error structure and logit link, except
GAM allows for non-linear relationships between
co-infection and age (e.g., [15]). We used the
Akaike Information Criterion (AIC), where a
lower AIC indicates a more informative model, to
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determine which terms should remain in the
model. We started with a saturated model and
proceeded to drop interactions and then main ef-
fects if their deletion reduced AIC.
(ii)Associations between pairs of infections
For each pair of infections we tested whether the
number of deaths involving both infections was
different from that expected in the absence of any
association using a Chi-squared test. Every co-
occurring infection was included in this analysis such
that a death certificate reporting three infections
would have contributed three pairs. The residuals
from this analysis were used to quantify the disparity
between the observed and expected frequencies of co-
infection death; a negative residual indicated fewer co-
infection deaths than expected, while a positive
residual indicated more than expected. To account for
infections being reported with different frequency, we
report Pearson standardised residuals [16].
(iii)Are biologically similar infections associated with
co-infection death?
We tested whether the measured associations
between each pair of infections were related to the
biological similarity between them, based on four
characteristics: taxonomy, transmission, tropism,
and timescale (see Additional file 1: Supplementary
Information S2 for details). For each infection we
gathered data on each characteristic using
PubMedHealth [17], a human infection database
[18], and an RNA virus database [19].
Pairwise similarity between each pair of infections
was calculated as the number of matching
characteristics (zero – four). We used a Mantel test
[20] to measure the correlation coefficient between
the matrix of pairwise biological similarities and the
matrix of pairwise associations on death certificates
(standardised Chi-squared residual values).
All analyses were done in R version 3.1.0 [21],
including using the mgcv package to fit GAMs and
calculate AIC [22] and the ade4 package for Mantel
tests [23].
Results
From the 9,769,977 death certificates in the USA be-
tween 2005 and 2008, 732,079 (7.5 %, 369,646 female
and 362,433 male) attributed death to one infection,
while 84,311 (0.9 %, 33,513 female and 50,798 male) at-
tributed death to multiple infections. From the 2,028,734
death certificates in England and Wales between 2005
and 2008, 130,758 (6.4 %, 72,080 female and 58,678
male) attributed death to one infection, while 8695
(0.4 %, 4623 female, 4072 male) attributed death to mul-
tiple infections.
(i) Age, sex, and co-infection death
In the USA, and England and Wales, the proportion
of deaths attributed to co-infection rose from the
youngest age classes, peaking during adulthood
(fitted value ± se: 0.386 ± 0.004 for males at 30 and
0.294 ± 0.005 for females at 28 in the USA and
0.205 ± 0.010 for males at 40 and 0.209 ± 0.013 for
females at 35 in England and Wales), and then sub-
siding to low levels in the older age categories (Fig. 1,
binomial GAM with age spline by sex, lowest at age
85 for males [0.056 ± 0.001] and 85 for females [0.059
± 0.001] in the USA and at age 75 for males [0.052 ±
0.002] and 67 for females [0.055 ± 0.001] in England
and Wales). The peak age of co-infection death was
later in males than females (Fig. 1, removing the age:-
sex interaction increased AIC by 459 [USA] and 39
[England and Wales]).
To test the sensitivity of this result to our
analytical methods we tested for associations
between co-infection death, age, and sex using
other settings; in all instances we found omission
of the age:sex interaction to increase AIC by at
least 25 (Additional file 1: Table S1).
(ii)Associations between pairs of infections
Of 9453 possible pairings from 138 infections
reported on death certificates in the USA, 1067
(11 %) co-occurred on death certificates. Of 4560
possible pairings from 96 infections reported on
death certificates in England and Wales, 366 (8 %)
co-occurred on death certificates.
Most pairs co-occurred less often than expected,
indicated by the positive skew in Chi-squared
residuals (Fig. 2, USA: 91.2 % had a negative
standardised residual; England and Wales: 94.2 %
had a negative standardised residual).
Nevertheless, the strongest associations tended to be
positive. For example, the proportion of pairs
with residuals greater than 5 is 5.05 % in the
USA, and less than −5 is 1.24 %. And for England
and Wales these proportions are 2.81 and 1.55 %.
The longer positive tails on the distribution were
also found for non-standardised and adjusted
residuals, particularly for the USA data
(Additional file 1: Figures S1 and S2).
(iii)Are biologically similar infections associated with
co-infection death?
There were 3501 pairs of associated infections
reported in both the USA and England and Wales.
Standardised residuals in both countries were
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positively correlated (Additional file 1: Figure S3, r =
0.32, df = 3499, 95 % CI 0.303–0.345). Hence, most of
these pairs of infections (3089/3501, 88.2 %) had
the same direction of association in both
countries and we have greater certainty over their
co-occurrence. Pairs with the strongest negative
residuals in both countries were A41 Other septi-
caemia and A04 Other bacterial intestinal
infections (standardised residual −143 in England
and Wales and −206 USA), A41 and B18 Chronic
Fig. 1 Proportion of infection-related deaths reported due to co-infection in the USA (left) and England and Wales (right). Points are the observed
proportions of co-infection death among death certificates reporting at least one infection. Solid lines are the fitted binomial GAM (female = red,
male = blue). Dashed lines are two standard errors above and below the fitted values
Fig. 2 Distribution of association of pairs of infections on death certificates in the USA (left) and England and Wales (right). Solid black lines are
the density curves of standardised residuals for the number of co-infection deaths from Chi-squared tests. Vertical dashed grey line at zero
residual. Inset shows the whole distribution
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viral hepatitis (−307 and −32), A41 and A49 Bacterial
infection of unspecified site (−125 and −64), and A41
and B24 Unspecified HIV disease including AIDS
(−142 and −31; see http://figshare.com/preview/_url/
1328406/project/3684 for residuals of all pairs in both
countries). We used these pairs with similar co-
occurrence in both countries to investigate how co-
occurrence on death certificates was associated with
biological similarity between each pair of infections.
The standardised chi-squared residual for a pair of
infections was positively correlated with the number
of shared biological characteristics (Mantel test with
100 repetitions simulated mean ± 2sd: 0.24 ± 0.17).
In other words, infections that co-occurred more often
than expected tended to have more characteristics in
common. Co-occurring pairs tended to share each
characteristic (separate Mantel tests with 100
repetitions: tropism 0.19 ± 0.14, transmission 0.12 ±
0.11, taxonomy 0.15 ± 0.13, timescale 0.18 ± 0.17,
Additional file 1: Figure S4).
To test the sensitivity of this result to our
analytical methods we also tested for associations
using data for each country alone, and using
linear regression between the number of shared
characteristics and the Chi-squared residual. In all
instances we found a strength of association
whose confidence intervals did not overlap zero
(Additional file 1: Supplementary Information S4).
Discussion
Humans can get many different co-infections, but treat-
ment guidelines only exist for a few specific combina-
tions (e.g., HIV and hepatitis C). Co-infection morbidity
has also been studied within certain cohorts (e.g., 5–16
year olds, [15]), and is often reported to be worse than
single infections [4]. However, the occurrence of co-
infection in death across age and sex cohorts has, to our
knowledge, never been studied before. Our results indi-
cate that (i) co-infection death may be more common in
early adulthood, but it is not known whether younger
adults are more susceptible to co-infection per se, or
more susceptible to fatal co-infection. We also found
that (ii) pairs of infections with strong positive associ-
ation on death certificates tended to co-occur more
often than those with strong negative associations. This
suggests that medical care of severely ill patients with
some co-infections can be problematic. Finally, (iii) co-
occurrence on death certificates was positively related
to biologically similarity. Better understanding of these
biological interactions may help efforts to predict and
combat co-infection mortality. We discuss the factors
that may contribute to these patterns, before considering
implications for treatment, limitations of the data, and fu-
ture research needs.
Possible causes
The early-to-mid adulthood peak in co-infection death
contrasts with theories that the immune response de-
clines in old age [5], and with non-infectious diseases
where comorbidities increase with age [24]. This could
be explained by individuals being more susceptible to
death from one infection in old age, either because they
are frailer as their bodies deteriorate through oxidative
damage [25], or the infection coincides with non-
infectious causes of death that are more common with
age, like cancer [26]. Alternatively, young adults are
more prone to severe immunopathologies following in-
fection: critically ill patients with influenza A(H1N1)
tended to be 20–30 years old [27], and the added
physiological stress of co-infection might make death
more likely. Another possibility is that more effort is
made to find infections in critically ill young adults
than for older patients. We are not aware of evidence
that biased medical practices also contribute alongside
the physiological factors mentioned above, but this is a
possibility that could be examined further.
Reasons for males being at higher risk of infection
than females include behaviours that put them at greater
risk of infection, or physiological reasons, such as sex
hormones, that make them more susceptible to severe
disease once infected [7, 28]. Our data do not enable us
to distinguish which of these mechanisms may have
played a role. If males undertake riskier behaviour, have
higher testosterone in early adulthood, or are less likely
to visit the doctor when ill this may explain why the sex
difference appears around the peak of the distribution
(Fig. 1).
Treatment implications
Our results suggest that co-infection treatment guide-
lines could be based on synergistic interactions between
infections. Most possible pairs of infections co-occurred
on death certificates at a frequency expected from their
occurrence alone. We suggest that the unassociated
pairs of infections could be excluded from efforts seek-
ing to identify severe co-infections.
Around 1 in 20 possible pairs were associated and
tended to co-occur more often than expected. Positively
associated pairs of reported co-infections included:
mycobacteria and HIV, viral hepatitis co-infection, and
cytomegalovirus and pneumocystis. While these similar
pairings were often reported together, associations were
context dependent; they were negatively associated with
other infections, including mycobacteria and infectious
bloody diarrhoea, pneumocystis and sequelae of tubercu-
losis, and viral hepatitis and Zoster virus infection. The
direction of association is therefore not consistent for
the same infection, and so treatment guidelines should
not be based solely on the identity of one constituent
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infection. Whether the relatively weak correlations are
clinically meaningful remains a debatable point, but on a
population scale, across hundreds of thousands of
deaths, the results suggest that it may be important to
public health and worthy of further investigation. The
biological similarity of associated pairs could be an im-
portant consideration when assessing the potential se-
verity of a given co-infection.
Data quality and limitations
Studies based on reported data must consider potential
biases. In our dataset there may be underreporting of
co-infection death on death certificates if infectious dis-
ease was undetected, wrongly deemed not to have con-
tributed to death, or were not reported using multiple
codes. Poor reporting of causes of death was a problem
in the UK in the 1990s [29]. There have since been legal
and educational reforms [30], and death certificate data
have been audited by the Center for Disease Control and
the Office for National Statistics. Using multiple infec-
tious causes as indicators of co-infection probably un-
derestimates the true number of co-infection deaths.
One could hypothesise that certain types of infections,
such as those detected by the same test, with similar
tropism, of high severity, might be more likely to be di-
agnosed. However, from death certificates alone we are
unable to examine whether behaviour or diagnostic
techniques may have played a role. We have no evi-
dence of systematic bias that could have generated the
patterns we found, but we encourage further broad
scale analyses of co-infection to help establish the key
factors of the individual and their infections that can
best guide treatment. Our conclusions are robust to the
complexity of model fitted (Additional file 1: Supple-
mentary Information S1), measure of association used
(Additional file 1: Supplementary Information S2),
country and method for analysing biological similarity
(Additional file 1: Supplementary Information S3 and
S4), ambiguity in ICD-10 codes (Additional file 1:
Supplementary Information S5), and inpatient status
(Additional file 1: Supplementary Information S6).
Therefore, we are confident that we describe genuine
patterns.
Other limitations to the secondary data available in-
clude: an inability to distinguish certain pathogens
within the ICD-10 disease codes, severity of disease not
necessarily corresponding with both infections being of
the same timescale, and the age categories reported be-
ing somewhat arbitrary and not matching physiological
changes like puberty.
Further research
Causes of death are associated with various factors includ-
ing healthcare, socioeconomic status, family structure,
geography, behaviour, physiology, or infectious dose. De-
termining what factors affect causes of death using na-
tional observational data alone is difficult. Co-infection
death needs to be assessed in other time periods and
countries.
The patterns we described could be attributed to bio-
logical interactions, or an artefact of the relative preva-
lence of the infections among at-risk populations. To
disentangle the two we need data on co-infection preva-
lence. While we have some evidence that the number of
reported infection deaths is not correlated with re-
ported infections in England and Wales (Additional file
1: Supplementary Information S7), this was only for a
subset of infections, and we could not find data on
prevalence for most co-infections in our dataset.
Conclusions
We studied co-infection mortality across infections,
from viruses to helminths, and found several patterns
not previously described: (i) the positive skew among
thousands of pairs of reported infections, (ii) the distri-
bution of co-infection deaths across age and sex cohorts,
and (iii) the tendency for biologically similar infections
to associate positively with reported co-infection mortal-
ity. Having described these broad scale patterns we can
now put particular co-infection studies in context, and help
target healthcare appropriately to prevent co-infection
death.
Additional file
Additional file 1: Supplementary analyses including table S1 and
supplementary figures S1 to S10. (DOCX 3588 kb)
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